Preliminary results

I happened to see a summary of results from a recent trial of a hormonal contraceptive for men. Some of the details: “[T]here were no major adverse reactions to treatment and no deaths. Roughly one-third of subjects had a side effect from the study, the most common of which was weight gain.” Also, “The rate of ‘azoospermia’, that is, a sperm count of zero was 90% in the group which received testosterone injections every 4 weeks and 75% in the groups which received testosterone injections every six weeks.” I’d feel better about higher rates of azoospermia, and I’m not sure I’d be willing to get a shot in the ass every four weeks. Maybe, though. Anyway, “The company with which we collaborated, Organon Pharmaceuticals, is excited about these results and is therefore funding a larger Phase IIb trial of 350 men in 14 countries based on a similar regimen. If the regimen continues to be safe and effective in this upcoming Phase IIb trial, Organon will use the results from our completed study and the Phase III trial to apply for FDA approval for this method and men will finally have a contraceptive option besides condoms, vasectomy and abstinence.” And that will be a good thing.